M - KAST

Montelukast

Composition:

M-Kast 4 ODT: Each Orodispersible Tablet Contains Montelukast USP 4mg.

M-Kast 5 ODT:Each Orodispersible Tablet Contains Montelukast USP 5mg.

M-Kast10:Each Tablet Contains Montelukast USP 10mg

Indications:Montelukast Sodium is indicated for: 1. Prophylaxis and chronic treatment of asthma. 2. Acute prevention of Exercise-Induced Bronchoconstriction (EIB). 3. Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis.

Dosage and administration: Adult Dosage:Adults and adolescents with asthma or seasonal allergic rhinitis: (The dosage for adults and adolescents 15 years of age and older): Montelukast 10 mg tablet once daily. Pediatric patients with asthma or seasonal allergic rhinitis: (The dosage for pediatric patients 6 to 14 years of age): Montelukast 5 mg tablet once daily. (The dosage for pediatric patients 2 years to 5 years of age): Montelukast 4 mg tablet once daily. (The dosage for pediatric patients 6 months to 5 years of age): Montelukast 4 mg once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature. Elderly use: The pharmacokinetic profile and the oral bioavailability of a single 10 mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required. Hepatic

Insufficiency: No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency. Renal Insufficiency: No dosage adjustment is recommended in patients with renal insufficiency. Or, as directed by the registered physician.

Use in Pregnancy and lactation:Pregnancy category B. There are no adequate and well controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this medicine is excreted in human milk. However, other corticosteroids have been detected in human milk. Caution should be exercised when this medicine is administered to a nursing woman.

Packing:M-Kast 4 ODT:Each box contains 3x14’s tablets in blister pack.

M-Kast 5 ODT:Each box contains 3x14’s tablets in blister pack.

M-Kast10:Each box contains 3x14’s tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.